International Journal of Science and Research Archive,
Год журнала:
2024,
Номер
12(2), С. 1232 - 1235
Опубликована: Июль 30, 2024
The
filamentous
fungus
that
causes
Mucormycosis
is
a
newly
discovered
angiogenic
infection
found
in
large
quantities
and
member
of
the
Zygomycete
class's
Mucorales
order.
In
patients
undergoing
hematopoietic
allogeneic
stem
cell
transplantation,
after
candidiasis
aspergillosis,
mucormycosis
has
become
third
most
common
invasive
mycosis.
Breathing
sporangiospores
daily
need.
remarkably
low
frequency
members
nasal
mucus
indicates
airborne
contamination
either
minimal
or
mucociliary
transport
removes
spores
from
airway
mucus.
this
review
research,
new
approaches
to
assessing
relationships
among
host,
fungus,
antifungal
drugs
are
provided.
Aerosols
other
novel
delivery
methods
might
also
aid
treatment
mucormycosis.
Pathogens,
Год журнала:
2023,
Номер
12(2), С. 293 - 293
Опубликована: Фев. 10, 2023
Fungal
infections
are
a
serious
global
concern
because
of
their
ability
to
spread
and
colonize
host
tissues
in
immunocompromised
individuals.
Such
have
been
frequently
reported
worldwide
currently
gaining
clinical
research
relevance
owing
resistant
character,
representing
bottleneck
treating
affected
people.
Resistant
fungi
an
emergent
public
health
threat.
The
upsurge
such
pathogens
has
led
new
toward
unraveling
the
destructive
potential
evoked
by
these
species.
Some
fungi—grouped
into
Candida,
Aspergillus,
Cryptococcus—are
causative
agents
severe
systemic
infections.
They
associated
with
high
mortality
rates
recently
described
as
sources
coinfection
COVID-hospitalized
patients.
Despite
efforts
elucidate
challenges
colonization,
dissemination,
infection
severity,
immunopathogenesis
fungal
diseases
remains
pivotal
characteristic
burden
elimination.
struggle
between
immune
system
physiological
strategies
maintain
cellular
viability
is
complex.
In
this
brief
review,
we
highlight
drug
resistance
phenotypes
significance,
taking
consideration
physiopathology
how
scientific
community
could
orchestrate
avoid
dissemination
deaths.
Diabetes
mellitus
(DM)
is
one
of
the
most
common
chronic
metabolic
disorders
worldwide,
which
increases
risk
and
opportunistic
infections.
Following
coronavirus
disease
2019
(COVID-19)
pandemic,
a
higher
incidence
rate,
more
severe
forms
disease,
exacerbation
hyperglycemia
its
complications
have
been
observed
in
patients
with
DM.
Moreover,
stress-induced
has
many
hospitalized
nondiabetic
after
contracting
COVID-19.
Hyperglycemia
worsens
prognosis
both
diabetic
patients.
In
this
study,
mechanism
new-onset
or
hyperglycemia,
effect
treatments
used
for
COVID-19
on
importance
appropriate
method
blood
glucose
(blood
sugar
(BS))
control
during
possible
fate
recovery
from
to
some
extent
expressed.
Annals of Medicine,
Год журнала:
2024,
Номер
56(1)
Опубликована: Сен. 2, 2024
Aim
This
review
aims
to
summarize
the
epidemiology,
etiology,
pathogenesis,
clinical
manifestations,
and
current
diagnostic
therapeutic
approaches
for
mucormycosis.
The
goal
is
improve
understanding
of
mucormycosis
promote
early
diagnosis
treatment
reduce
mortality.
Vaccines,
Год журнала:
2023,
Номер
11(3), С. 555 - 555
Опубликована: Фев. 27, 2023
Coronavirus
disease
2019
(COVID-19)
infection
is
currently
a
great
cause
of
concern
for
the
healthcare
sector
around
globe.
SARS-CoV-2
an
RNA
virus
that
causes
serious
associated
with
numerous
adverse
effects
and
multiple
complications
different
organs
systems
during
its
pathogenic
cycle
in
humans.
Individuals
affected
by
COVID-19,
especially
elderly
populations
immunocompromised
people,
are
greatly
vulnerable
to
opportunistic
fungal
pathogens.
Aspergillosis,
invasive
candidiasis,
mucormycosis
widespread
coinfections
COVID-19
patients.
Other
infections
rare
but
exhibiting
increased
incidence
current
scenario
include
caused
Pneumocystis
jirovecii,
Histoplasma
sp.,
Cryptococcus
etc.
By
producing
virulent
spores,
these
pathogens
increase
severity
morbidity
fatality
rates
patients
globally.
These
generally
occur
recovering
from
infection,
resulting
rehospitalization.
Older
individuals
at
higher
risk
developing
infections.
This
review
focuses
on
understanding
prevalent
patients,
people.
We
have
also
highlighted
important
preventive
methods,
diagnostic
approaches,
prophylactic
measures
Future Microbiology,
Год журнала:
2023,
Номер
18(3), С. 217 - 234
Опубликована: Фев. 1, 2023
Mucormycosis
is
an
emerging
opportunistic
angioinvasive
fungal
infection.
Predisposing
factors
such
as
diabetes,
neutropenia,
long-term
corticosteroid
therapy,
solid
organ
transplantation
and
immunosuppression
contribute
to
its
occurrence.
This
disease
was
not
of
significant
concern
prior
the
COVID-19
pandemic,
but
gained
prominence
due
infections
in
patients.
needs
special
attention
coordinated
efforts
scientific
community
medical
professionals
reduce
morbidity
mortality.
Here
we
present
overview
epidemiology
prevalence
mucormycosis
pre-
post-COVID-19
eras,
that
contributed
abrupt
increase
COVID-19-associated
(CAM),
actions
taken
by
regulatory
agencies
(including
Code
Mucor
CAM
registry),
existing
diagnostic
tools
management
strategies.
PLoS ONE,
Год журнала:
2022,
Номер
17(7), С. e0271333 - e0271333
Опубликована: Июль 11, 2022
Objectives
This
systematic
review
aims
to
summarize
the
mycological
and
clinical
features
of
COVID-19-associated
fungal
infections
(CAFIs)
in
Iran.
Methods
PubMed,
Web
Science,
Scopus,
Cochrane
Library,
SID,
Magiran,
IranDoc,
Google
Scholar
were
searched
for
Persian
English
articles
published
from
January
1,
2020,
November
5,
2021,
using
a
search
strategy.
Studies
on
Iranian
patients
suffering
CAFIs
included
review.
Results
Twenty-two
studies
comprising
169
retrieved.
Reported
candidiasis
(85,
50.30%),
mucormycosis
(35,
20.71%),
aspergillosis
(29,
17.16%),
fusariosis
(6,
3.55%),
three
cases
caused
by
rare
pathogens
(Rhodotorula
mucilaginosa
,
Diaporthe
foeniculina
Sarocladium
kiliense
)
11
(6.51%)
uncharacterized
mold
infections.
The
most
common
underlying
diseases
diabetes
(67/168,
39.88%),
cardiovascular
(55/168,
32.74%),
hypertension
(43/168,
25.59%).
use
antibiotics
(111/124,
89.52%),
corticosteroids
(93/132,
70.44%),
mechanical
ventilation
(66,
51.16%)
predisposing
factors.
Totally,
72
(50.35%)
143
with
died
(data
not
available
26
patients).
Conclusion
Fungal
are
evident
be
complication
COVID-19
Iran;
thus,
clinicians
should
consider
them
as
differential
diagnosis,
especially
comorbidities
previous
antibiotic
or
corticosteroid
use.
Frontiers in Cellular and Infection Microbiology,
Год журнала:
2024,
Номер
14
Опубликована: Июль 16, 2024
Rhino-orbital-cerebral
mucormycosis
(ROCM)
is
a
rare,
invasive,
and
fatal
fungal
disease
that
often
easily
misdiagnosed
in
the
early
stages
due
to
lack
of
specific
clinical
manifestations
adequate
auxiliary
examinations.
Early
diagnosis
timely
therapy
are
essential
for
successful
treatment.
In
this
report,
we
presented
46-year-old
man
with
diabetes
who
experienced
gradual
vision
loss,
right
ptosis,
swelling,
headaches
progressively
worsened
death
within
4
days
after
admission.
It
was
finally
confirmed
as
Rhizopus
arrhizus
infection
by
metagenomics
next-generation
sequencing
(mNGS).
Our
report
has
proved
mNGS
testing
should
be
strongly
recommended
highly
suspected
patients.
Journal of Infection and Public Health,
Год журнала:
2022,
Номер
15(11), С. 1299 - 1314
Опубликована: Окт. 14, 2022
As
of
25th
July,
2022,
global
Disease
burden
575,430,244
confirmed
cases
and
over
6,403,511
deaths
have
been
attributed
to
coronavirus
disease
2019
(COVID-19).
Co-infections/secondary
infections
continue
plague
patients
around
the
world
as
result
co-morbidities
like
diabetes
mellitus,
biochemical
changes
caused
by
Severe
Acute
Respiratory
Syndrome
Coronavirus-2
(SARS-CoV-2)
especially
significant
elevation
in
free
iron
levels,
immune
suppression
SARS-CoV-2,
indiscriminate
use
systemic
corticosteroids
for
treatment
severe
COVID-19
disease.
In
such
circumstances,
opportunistic
fungal
pose
challenge
therapy
with
other
co-morbidities.
Although
COVID-19-associated
Mucormycosis
(CAM)
has
widely
recognized,
currently
extensive
research
is
being
conducted
on
mucormycosis.
It
agreed
that
undergoing
corticosteroid
are
highly
susceptible
CAM,
henceforth
high
index
screening
intensive
care
management
need
an
hour
order
favorable
outcomes
these
patients.
Diagnosis
often
delayed
eventually
progresses
quickly
which
poses
added
clinician
increases
patient
load
critical
units
hospitals.
A
vast
perusal
literature
indicated
mellitus
those
might
be
vulnerable
develop
present
work,
case
series
three
presented
at
Chest
Hospital
Srinagar,
Jammu
Kashmir
infected
CAM
described
their
epidemiological
data
supplementary
section.
All
were
found
affected
co-morbidity
Diabetes
Mellitus
(DM)
under
therapy.
Furthermore,
given
death
rate
linked
mucormycosis
growing
understanding
diseases
significance,
systematic
review
discussed
we
attempted
discuss
emerging
related
aspects